LECT2 Ameliorates Blood–Retinal Barrier Impairment Secondary to Diabetes Via Activation of the Tie2/Akt/mTOR Signaling Pathway

PURPOSE: Current treatments for diabetic retinopathy (DR) have considerable limitations, emphasizing the need for new therapeutic options. The effect of leukocyte cell-derived chemotaxin 2 (LECT2) on diabetes-induced blood–retinal barrier impairment and the possible underlying mechanism were investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Yuan-Jun, Xiao, Ke, Zhong, Zheng, Zhao, Yin, Yu, Tian, Sun, Xu-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2022
Materias:
Retina
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934553/
https://www.ncbi.nlm.nih.gov/pubmed/35262733
http://dx.doi.org/10.1167/iovs.63.3.7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934553/
https://www.ncbi.nlm.nih.gov/pubmed/35262733
http://dx.doi.org/10.1167/iovs.63.3.7

Ejemplares similares